Metraipolis › archive › dc_205e2a954535

Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer — Europe PMC PMID:42192962

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42192962
DOI
10.3390/cancers18101602
License (as archived)
solo-consultazione
Archived
2026-11-02T06:32:52.471Z
SHA-256 of the archived text
61dd93cca152cf341e099a7128648ddb18af0f85933c3df934dc5e6bc167182e
Stable URL of this page
https://metraipolis.com/documento/dc_205e2a954535

How to cite

Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer — Europe PMC PMID:42192962 — Europe PMC (en), https://europepmc.org/article/MED/42192962 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_205e2a954535 (Metraipolis archive dc_205e2a954535, sha256 61dd93cca152cf341e099a7128648ddb18af0f85933c3df934dc5e6bc167182e)
BibTeX
@misc{dc205e2a954535,
  title = {Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast Cancer — Europe PMC PMID:42192962},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192962},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_205e2a954535; sha256 61dd93cca152cf341e099a7128648ddb18af0f85933c3df934dc5e6bc167182e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192962. Agents can read the archived copy with the MCP tool read_document.